O	0	6	Effect
O	7	9	of
B-intervention	10	16	second
I-intervention	17	22	timed
I-intervention	23	35	appointments
O	36	39	for
O	40	43	non
O	43	44	-
O	44	53	attenders
O	54	56	of
O	57	63	breast
O	64	70	cancer
O	71	80	screening
O	81	83	in
B-location	84	91	England
O	91	92	:
O	93	94	a
O	95	105	randomised
O	106	116	controlled
O	117	122	trial
O	122	123	.

O	124	126	In
O	127	134	England
O	134	135	,
O	136	149	participation
O	150	152	in
O	153	159	breast
O	160	166	cancer
O	167	176	screening
O	177	180	has
O	181	185	been
O	186	196	decreasing
O	197	199	in
O	200	203	the
O	204	208	past
O	209	211	10
O	212	217	years
O	217	218	,
O	219	230	approaching
O	231	234	the
O	235	243	national
O	244	251	minimum
O	252	260	standard
O	261	263	of
O	264	266	70
O	266	267	%
O	267	268	.

O	269	282	Interventions
O	283	288	aimed
O	289	291	at
O	292	301	improving
O	302	315	participation
O	316	320	need
O	321	323	to
O	324	326	be
O	327	339	investigated
O	340	343	and
O	344	347	put
O	348	352	into
O	353	361	practice
O	362	364	to
O	365	369	stop
O	370	374	this
O	375	383	downward
O	384	389	trend
O	389	390	.

O	391	393	We
O	394	402	assessed
O	403	406	the
O	407	413	effect
O	414	416	on
O	417	430	participation
O	431	433	of
O	434	441	sending
O	442	453	invitations
O	454	457	for
O	458	464	breast
O	465	474	screening
O	475	479	with
O	480	481	a
O	482	487	timed
O	488	499	appointment
O	500	502	to
O	503	508	women
O	509	512	who
O	513	516	did
O	517	520	not
O	521	527	attend
O	528	533	their
O	534	539	first
O	540	547	offered
O	548	559	appointment
O	560	566	within
O	567	570	the
O	571	574	NHS
O	575	581	Breast
O	582	591	Screening
O	592	601	Programme
O	602	603	(
O	603	609	NHSBSP
O	609	610	)
O	610	611	.

O	612	614	In
O	615	619	this
O	620	624	open
O	624	625	,
O	626	636	randomised
O	637	647	controlled
O	648	653	trial
O	653	654	,
B-eligibility	655	660	women
I-eligibility	661	663	in
I-eligibility	664	667	six
I-eligibility	668	675	centres
I-eligibility	676	678	in
I-eligibility	679	682	the
I-eligibility	683	689	NHSBSP
I-eligibility	690	692	in
I-eligibility	693	700	England
I-eligibility	701	704	who
I-eligibility	705	709	were
I-eligibility	710	717	invited
I-eligibility	718	721	for
I-eligibility	722	729	routine
I-eligibility	730	736	breast
I-eligibility	737	743	cancer
I-eligibility	744	753	screening
O	754	758	were
O	759	767	randomly
O	768	776	assigned
O	777	778	(
O	778	779	1
O	779	780	:
O	780	781	1
O	781	782	)
O	783	785	to
O	786	793	receive
O	794	796	an
O	797	807	invitation
O	808	810	to
O	811	812	a
O	813	819	second
O	820	831	appointment
O	832	836	with
O	837	842	fixed
O	843	847	date
O	848	851	and
O	852	856	time
O	857	858	(
O	858	870	intervention
O	870	871	)
O	872	874	or
O	875	877	an
B-control	878	888	invitation
I-control	889	895	letter
I-control	896	900	with
I-control	901	902	a
I-control	903	912	telephone
I-control	913	919	number
I-control	920	922	to
I-control	923	927	call
I-control	928	930	to
I-control	931	935	book
I-control	936	941	their
I-control	942	945	new
I-control	946	955	screening
I-control	956	967	appointment
I-control	968	969	(
I-control	969	976	control
I-control	976	977	)
O	978	980	in
O	981	984	the
O	985	990	event
O	991	993	of
O	994	997	non
O	997	998	-
O	998	1008	attendance
O	1009	1011	at
O	1012	1015	the
O	1016	1021	first
O	1022	1029	offered
O	1030	1041	appointment
O	1041	1042	.

O	1043	1056	Randomisation
O	1057	1060	was
O	1061	1063	by
O	1064	1066	SX
O	1067	1073	number
O	1073	1074	,
O	1075	1076	a
O	1077	1087	sequential
O	1088	1094	unique
O	1095	1105	identifier
O	1106	1108	of
O	1109	1113	each
O	1114	1119	woman
O	1120	1126	within
O	1127	1130	the
O	1131	1137	NHSBSP
O	1137	1138	,
O	1139	1142	and
O	1143	1145	at
O	1146	1149	the
O	1150	1159	beginning
O	1160	1162	of
O	1163	1166	the
O	1167	1172	study
O	1173	1174	a
O	1175	1179	coin
O	1180	1184	toss
O	1185	1192	decided
O	1193	1200	whether
O	1201	1206	women
O	1207	1211	with
O	1212	1215	odd
O	1216	1218	or
O	1219	1223	even
O	1224	1226	SX
O	1227	1234	numbers
O	1235	1240	would
O	1241	1243	be
O	1244	1253	allocated
O	1254	1256	to
O	1257	1260	the
O	1261	1273	intervention
O	1274	1279	group
O	1279	1280	.

O	1281	1286	Women
O	1287	1291	aged
B-age	1292	1294	50
I-age	1294	1295	-
I-age	1295	1297	70
I-age	1298	1303	years
O	1304	1307	who
O	1308	1311	did
O	1312	1315	not
O	1316	1322	attend
O	1323	1328	their
O	1329	1334	first
O	1335	1342	offered
O	1343	1354	appointment
O	1355	1359	were
O	1360	1368	eligible
O	1369	1372	for
O	1373	1376	the
O	1377	1385	analysis
O	1385	1386	.

O	1387	1390	The
O	1391	1398	primary
O	1399	1407	endpoint
O	1408	1411	was
B-outcome-Measure	1412	1425	participation
O	1426	1427	(
O	1427	1429	ie
O	1429	1430	,
O	1431	1441	attendance
O	1442	1444	at
O	1445	1451	breast
O	1452	1458	cancer
O	1459	1468	screening
O	1468	1469	)
O	1470	1476	within
O	1477	1479	90
O	1480	1484	days
O	1485	1487	of
O	1488	1491	the
O	1492	1496	date
O	1497	1499	of
O	1500	1503	the
O	1504	1509	first
O	1510	1517	offered
O	1518	1529	appointment
O	1529	1530	;
O	1531	1533	we
O	1534	1538	used
O	1539	1546	Poisson
O	1547	1557	regression
O	1558	1560	to
O	1561	1568	compare
O	1569	1572	the
O	1573	1583	proportion
O	1584	1586	of
O	1587	1592	women
O	1593	1596	who
O	1597	1609	participated
O	1610	1612	in
O	1613	1622	screening
O	1623	1625	in
O	1626	1629	the
O	1630	1635	study
O	1636	1642	groups
O	1642	1643	.

O	1644	1647	All
O	1648	1656	analyses
O	1657	1661	were
O	1662	1664	by
O	1665	1674	intention
O	1675	1677	to
O	1678	1683	treat
O	1683	1684	.

O	1685	1689	This
O	1690	1695	trial
O	1696	1698	is
O	1699	1709	registered
O	1710	1714	with
O	1715	1720	Barts
O	1721	1727	Health
O	1727	1728	,
O	1729	1735	number
O	1736	1744	009304QM
O	1744	1745	.

O	1746	1748	We
O	1749	1757	obtained
B-total-participants	1758	1760	33
I-total-participants	1761	1764	146
O	1765	1772	records
O	1773	1775	of
O	1776	1781	women
O	1782	1789	invited
O	1790	1793	for
O	1794	1800	breast
O	1801	1807	cancer
O	1808	1817	screening
O	1818	1820	at
O	1821	1824	the
O	1825	1828	six
O	1829	1836	centres
O	1837	1844	between
O	1845	1849	June
O	1850	1851	2
O	1851	1852	,
O	1853	1857	2014
O	1857	1858	,
O	1859	1862	and
O	1863	1867	Sept
O	1868	1870	30
O	1870	1871	,
O	1872	1876	2015
O	1876	1877	,
O	1878	1881	who
O	1882	1885	did
O	1886	1889	not
O	1890	1896	attend
O	1897	1902	their
O	1903	1908	first
O	1909	1916	offered
O	1917	1928	appointment
O	1928	1929	.

B-total-participants	1930	1932	26
I-total-participants	1933	1936	054
O	1937	1942	women
O	1943	1947	were
O	1948	1956	eligible
O	1957	1960	for
O	1961	1965	this
O	1966	1974	analysis
O	1975	1976	(
B-intervention-participants	1976	1978	12
I-intervention-participants	1979	1982	807
O	1983	1985	in
O	1986	1989	the
O	1990	2002	intervention
O	2003	2008	group
O	2009	2012	and
B-control-participants	2013	2015	13
I-control-participants	2016	2019	247
O	2020	2022	in
O	2023	2026	the
O	2027	2034	control
O	2035	2040	group
O	2040	2041	)
O	2041	2042	.

B-outcome	2043	2056	Participation
O	2057	2063	within
O	2064	2066	90
O	2067	2071	days
O	2072	2074	of
O	2075	2078	the
O	2079	2084	first
O	2085	2092	offered
O	2093	2104	appointment
O	2105	2108	was
O	2109	2122	significantly
O	2123	2129	higher
O	2130	2132	in
O	2133	2136	the
O	2137	2149	intervention
O	2150	2155	group
O	2156	2157	(
B-iv-bin-abs	2157	2161	2861
O	2162	2163	[
B-iv-bin-percent	2163	2165	22
I-iv-bin-percent	2165	2166	%
O	2166	2167	]
O	2168	2170	of
B-intervention-participants	2171	2173	12
I-intervention-participants	2174	2177	807
O	2177	2178	)
O	2179	2183	than
O	2184	2186	in
O	2187	2190	the
O	2191	2198	control
O	2199	2204	group
O	2205	2206	(
B-cv-bin-abs	2206	2210	1632
O	2211	2212	[
B-cv-bin-percent	2212	2214	12
I-cv-bin-percent	2214	2215	%
O	2215	2216	]
O	2217	2219	of
B-control-participants	2220	2222	13
I-control-participants	2223	2226	247
O	2226	2227	)
O	2227	2228	;
O	2229	2237	relative
O	2238	2242	risk
O	2243	2245	of
O	2246	2259	participation
O	2260	2261	1
O	2261	2262	路
O	2262	2264	81
O	2265	2266	(
O	2266	2268	95
O	2268	2269	%
O	2270	2272	CI
O	2273	2274	1
O	2274	2275	路
O	2275	2277	70
O	2277	2278	-
O	2278	2279	1
O	2279	2280	路
O	2280	2282	93
O	2282	2283	;
O	2284	2285	p
O	2285	2286	<
O	2286	2287	0
O	2287	2288	路
O	2288	2292	0001
O	2292	2293	)
O	2293	2294	.

O	2295	2300	These
O	2301	2309	findings
O	2310	2314	show
O	2315	2319	that
O	2320	2321	a
O	2322	2328	policy
O	2329	2331	of
O	2332	2338	second
O	2339	2351	appointments
O	2352	2356	with
O	2357	2362	fixed
O	2363	2367	date
O	2368	2371	and
O	2372	2376	time
O	2377	2380	for
O	2381	2384	non
O	2384	2385	-
O	2385	2394	attenders
O	2395	2397	of
O	2398	2404	breast
O	2405	2414	screening
O	2415	2417	is
O	2418	2427	effective
O	2428	2430	in
O	2431	2440	improving
O	2441	2454	participation
O	2454	2455	.

O	2456	2460	This
O	2461	2469	strategy
O	2470	2473	can
O	2474	2476	be
O	2477	2483	easily
O	2484	2495	implemented
O	2496	2498	by
O	2499	2502	the
O	2503	2512	screening
O	2513	2518	sites
O	2519	2522	and
O	2522	2523	,
O	2524	2526	if
O	2527	2535	combined
O	2536	2540	with
O	2541	2547	simple
O	2548	2561	interventions
O	2561	2562	,
O	2563	2568	could
O	2569	2576	further
O	2577	2585	increase
O	2586	2599	participation
O	2600	2603	and
O	2604	2610	ensure
O	2611	2613	an
O	2614	2620	upward
O	2621	2626	shift
O	2627	2629	in
O	2630	2633	the
O	2634	2647	participation
O	2648	2653	trend
O	2654	2664	nationally
O	2664	2665	.

O	2666	2673	Whether
O	2674	2677	the
O	2678	2684	policy
O	2685	2691	should
O	2692	2696	vary
O	2697	2699	by
O	2700	2704	time
O	2705	2710	since
O	2711	2715	last
O	2716	2724	attended
O	2725	2731	screen
O	2732	2736	will
O	2737	2741	have
O	2742	2744	to
O	2745	2747	be
O	2748	2758	considered
O	2758	2759	.

O	2760	2768	National
O	2769	2775	Health
O	2776	2783	Service
O	2784	2790	Cancer
O	2791	2800	Screening
O	2801	2811	Programmes
O	2812	2815	and
O	2816	2826	Department
O	2827	2829	of
O	2830	2836	Health
O	2837	2843	Policy
O	2844	2852	Research
O	2853	2862	Programme
O	2862	2863	.
